SCHEMBL5655735

SCHEMBL5655735

COc1ccccc1NC(=O)OCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.67
LMNA P02545 3/20 0.67
ALOX15 P16050 2/20 0.67
USP2 O75604 1/20 0.67
TP53 P04637 1/20 0.67
POLB P06746 1/20 0.67
HSD17B10 Q99714 1/20 0.67
HTR2A P28223 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.57
ABCB1 P08183 2/20 0.56
HTR4 Q13639 1/20 0.55
MAPT P10636 1/20 0.55
HTT P42858 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
DRD3 P35462 2/20 0.53
DRD2 P14416 1/20 0.53
KDM4E B2RXH2 1/20 0.52
TDP1 Q9NUW8 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5656029 0.94 TSHR (0.69) TSHRLMNAALOX15USP2TP53
SCHEMBL5657587 0.91 HTR2A (0.60) TSHRLMNAALOX15USP2TP53
SCHEMBL5657428 0.88 L3MBTL1 (0.62) L3MBTL1HTR4MEN1KMT2ADRD3
SCHEMBL5658292 0.88 HTR1A (0.63) TP53L3MBTL1ABCB1MAPTMEN1
SCHEMBL5654244 0.87 L3MBTL1 (0.75) TSHRL3MBTL1ABCB1HTR4MAPT
SCHEMBL9559576 0.86 HTR2A (0.61) TSHRLMNAALOX15USP2TP53
SCHEMBL5657864 0.86 L3MBTL1 (0.59) TSHRPOLBL3MBTL1HTR4MAPT
SCHEMBL5657071 0.84 NPSR1 (0.56) TSHRLMNAALOX15TP53POLB
SCHEMBL5656009 0.82 MEN1 (0.61) TSHRLMNAALOX15USP2TP53
SCHEMBL5658368 0.82 ADRA1D (0.60) TSHRTP53POLBHTR2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7238693-B2 Aryl carbamate derivatives, preparation and use thereof CEREP (FR) 2007-07-03 US disclosed
US-7238693-B2 Aryl carbamate derivatives, preparation and use thereof CEREP (FR) 2007-07-03 US disclosed
US-7238693-B2 Aryl carbamate derivatives, preparation and use thereof CEREP (FR) 2007-07-03 US disclosed
US-20040058933-A1 Aryl carbamate derivatives, preperation and use thereof CEREP (FR) 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058933-A1 Aryl carbamate derivatives, preperation and use thereof HTR4, HTR5A, HTR3C TSHR 487/4885LMNA 1137/4885ALOX15 1173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.